Category: Prescription Drugs

Durbin proposes crackdown on misleading prescription drug promotions

by Ryan Voyles | Sep 13, 2024 | Federal Government, Prescription Drugs, Top Stories | 0

Sen. Dick Durbin, D-Ill., this week proposed a new plan to address false and misleading prescription drug promotions by social media influencers and telehealth companies.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Lawmakers discuss role of PBMs with specialty drugs

by Ryan Voyles | Sep 12, 2024 | Legislature, Prescription Drugs, Top Stories | 0

Illinois lawmakers continued discussions this week about the role of pharmacy benefit managers, with a Wednesday hearing focused on the cost of specialty drugs.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

HHS Region V director extolls Inflation Reduction Act’s drug pricing reforms

by Ryan Voyles | Aug 30, 2024 | On The Record, Prescription Drugs, Top Stories | 0

Earlier this month, Medicare unveiled the fruits of its negotiations with pharmaceutical companies on 10 drugs. More than 280,000 Illinois Medicare enrollees take at least one of the medications.

Durbin, Duckworth call Medicare price negotiations ‘monumental’ for Illinoisans

by Tim Stumm | Aug 19, 2024 | Medicaid/Medicare, Prescription Drugs, Top Stories | 0

Illinois Democratic U.S. Sens. Dick Durbin and Tammy Duckworth said last week that Medicare’s first drug price negotiations will be “monumental” for hundreds of thousands of patients in the state.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.

Lawmakers seek further clarity on PBMs and potential impact on drug costs

by Ryan Voyles | Jul 24, 2024 | Legislature, Pharmacy, Prescription Drugs, Top Stories | 0

Illinois lawmakers continued discussions this week on the role of pharmacy benefit managers in light of a recent federal report that raised concerns about the drug middlemen's operations.

To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.